• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

嗅神经母细胞瘤的年龄分布及与年龄相关的预后:一项基于人群的分析。

Age distribution and age-related outcomes of olfactory neuroblastoma: a population-based analysis.

作者信息

Yin Zhenzhen, Wang Youyou, Wu Yuemei, Zhang Ximei, Wang Fengming, Wang Peiguo, Tao Zhen, Yuan Zhiyong

机构信息

Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin, People's Republic of China.

出版信息

Cancer Manag Res. 2018 May 29;10:1359-1364. doi: 10.2147/CMAR.S151945. eCollection 2018.

DOI:10.2147/CMAR.S151945
PMID:29881306
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5985786/
Abstract

OBJECTIVE

The objective of the study was to describe the age distribution and to evaluate the role of prognostic value of age on survival in patients diagnosed with olfactory neuroblastoma (ONB). A population-based retrospective analysis was conducted.

MATERIALS AND METHODS

The population-based study of patients in the Surveillance, Epidemiology, and End Results (SEER) tumor registry, who were diagnosed with ONB from 1973 to 2014, were retrospectively analyzed.

RESULTS

The cohort included 876 patients with a median age of 54 years. There was a unimodal distribution of age and ONBs most frequently occurred in the fifth to sixth decades of life. Kaplan-Meier analysis demonstrated overall survival (OS) and cancer-specific survival (CSS) rates of 69% and 78% at 5 years. Multivariable Cox regression analysis showed that age, SEER stage, and surgery were independent prognostic factors for CSS. The risk of overall death and cancer-specific death increased 3.1% and 1.6% per year, respectively. Patients aged >60 years presented significantly poor OS and CSS compared with patients aged ≤60 years, even in patients with loco-regional disease or in those treated with surgery.

CONCLUSION

This study highlights the growing evidence that there is a unimodal age distribution of ONB and that age is an important adverse prognostic factor.

摘要

目的

本研究的目的是描述年龄分布,并评估年龄对嗅神经母细胞瘤(ONB)患者生存的预后价值作用。进行了一项基于人群的回顾性分析。

材料与方法

对监测、流行病学和最终结果(SEER)肿瘤登记处中1973年至2014年被诊断为ONB的患者进行基于人群的研究,并进行回顾性分析。

结果

该队列包括876例患者,中位年龄为54岁。年龄呈单峰分布,ONB最常发生在50至60岁之间。Kaplan-Meier分析显示,5年总生存率(OS)和癌症特异性生存率(CSS)分别为69%和78%。多变量Cox回归分析表明,年龄、SEER分期和手术是CSS的独立预后因素。全因死亡风险和癌症特异性死亡风险分别每年增加3.1%和1.6%。与年龄≤60岁的患者相比,年龄>60岁的患者OS和CSS显著较差,即使是局部区域疾病患者或接受手术治疗的患者也是如此。

结论

本研究突出了越来越多的证据,即ONB存在单峰年龄分布,且年龄是一个重要的不良预后因素。

相似文献

1
Age distribution and age-related outcomes of olfactory neuroblastoma: a population-based analysis.嗅神经母细胞瘤的年龄分布及与年龄相关的预后:一项基于人群的分析。
Cancer Manag Res. 2018 May 29;10:1359-1364. doi: 10.2147/CMAR.S151945. eCollection 2018.
2
Survival Associations between Patient Age and Treatment Modality in Olfactory Neuroblastoma: A Retrospective Population-Based Study.嗅神经母细胞瘤患者年龄与治疗方式之间的生存关联:一项基于人群的回顾性研究。
J Clin Med. 2021 Jun 18;10(12):2685. doi: 10.3390/jcm10122685.
3
A Clinical Model of Bone Angiosarcoma Patients: A Population-based Analysis of Epidemiology, Prognosis, and Treatment.骨血管肉瘤患者的临床模型:基于人群的流行病学、预后和治疗分析。
Orthop Surg. 2020 Dec;12(6):1652-1662. doi: 10.1111/os.12803. Epub 2020 Sep 10.
4
[Efficacy analysis of radiotherapy combined with surgery for locally advanced rectal mucinous adenocarcinoma: a retrospective study based on data of Surveillance, Epidemiology, and End results population].局部晚期直肠黏液腺癌放疗联合手术的疗效分析:一项基于监测、流行病学和最终结果人群数据的回顾性研究
Zhonghua Wei Chang Wai Ke Za Zhi. 2019 Jan 25;22(1):85-93.
5
Survival Analysis of Patients with Osseous Malignant Vascular Tumors: Results of the Surveillance, Epidemiology, and End Results (SEER) Database from 1973 to 2015.骨质恶性血管肿瘤患者的生存分析:1973 年至 2015 年监测、流行病学和最终结果(SEER)数据库的结果。
Med Sci Monit. 2019 Jul 25;25:5525-5535. doi: 10.12659/MSM.914950.
6
Prognostic factors and outcomes of multimodality treatment in olfactory neuroblastoma.嗅神经母细胞瘤多模态治疗的预后因素和结果。
Oral Oncol. 2020 Apr;103:104618. doi: 10.1016/j.oraloncology.2020.104618. Epub 2020 Feb 29.
7
Clinical Characteristics and Survival Outcomes in Neuroblastoma With Bone Metastasis Based on SEER Database Analysis.基于监测、流行病学和最终结果(SEER)数据库分析的神经母细胞瘤骨转移的临床特征和生存结果
Front Oncol. 2021 Jun 1;11:677023. doi: 10.3389/fonc.2021.677023. eCollection 2021.
8
Radiotherapy and Male Breast Cancer: A Population-based Registry Analysis.放射治疗与男性乳腺癌:一项基于人群的登记分析。
Am J Clin Oncol. 2016 Oct;39(5):458-62. doi: 10.1097/COC.0000000000000078.
9
Esthesioneuroblastoma: a population-based analysis of survival and prognostic factors.嗅神经母细胞瘤:基于人群的生存及预后因素分析
Arch Otolaryngol Head Neck Surg. 2007 Mar;133(3):276-80. doi: 10.1001/archotol.133.3.276.
10
Importance of tumor grade in esthesioneuroblastoma survival: a population-based analysis.肿瘤分级对嗅神经母细胞瘤生存的重要性:基于人群的分析。
JAMA Otolaryngol Head Neck Surg. 2014 Dec;140(12):1124-9. doi: 10.1001/jamaoto.2014.2541.

引用本文的文献

1
SIADH as an uncommon presentation of olfactory neuroblastoma: a case-based overview.抗利尿激素分泌异常综合征作为嗅神经母细胞瘤的一种罕见表现:基于病例的概述
Endocr Oncol. 2025 Jul 7;5(1):e250021. doi: 10.1530/EO-25-0021. eCollection 2025 Jan.
2
Cancer Stem Cell Characterization in Olfactory Neuroblastoma Tissue.嗅神经母细胞瘤组织中的癌症干细胞特征分析
Int Forum Allergy Rhinol. 2025 Sep;15(9):1008-1011. doi: 10.1002/alr.23620. Epub 2025 Jun 25.
3
The 100 most-cited papers on esthesioneuroblastoma: a bibliometric analysis.关于嗅神经母细胞瘤的100篇被引用次数最多的论文:一项文献计量分析。

本文引用的文献

1
Long-term outcomes of patients with esthesioneuroblastomas: A cohort from a single institution.嗅神经母细胞瘤患者的长期预后:来自单一机构的队列研究。
Oral Oncol. 2016 Feb;53:48-53. doi: 10.1016/j.oraloncology.2015.11.021. Epub 2015 Dec 19.
2
Long-term outcome of esthesioneuroblastoma: hyams grade predicts patient survival.嗅神经母细胞瘤的长期预后:海姆斯分级可预测患者生存率。
J Neurol Surg B Skull Base. 2012 Oct;73(5):331-6. doi: 10.1055/s-0032-1321512.
3
Optimization of long-term outcomes for patients with esthesioneuroblastoma.
Ann Med Surg (Lond). 2025 Jan 21;87(2):711-719. doi: 10.1097/MS9.0000000000002933. eCollection 2025 Feb.
4
Ectopic olfactory neuroblastoma is associated with increased frequency of syndrome of inappropriate antidiuretic hormone secretion and reduced disease control: Case series with systematic review and pooled analysis.异位嗅神经母细胞瘤与抗利尿激素分泌不当综合征发生率增加及疾病控制不佳相关:病例系列并系统评价与汇总分析
Int Forum Allergy Rhinol. 2025 Jan;15(1):45-67. doi: 10.1002/alr.23502. Epub 2024 Dec 11.
5
Olfactory Neuroblastoma Is Not Always Located at the Roof of the Nasal Cavity.嗅神经母细胞瘤并不总是位于鼻腔顶部。
J Belg Soc Radiol. 2024 Apr 12;108(1):39. doi: 10.5334/jbsr.3562. eCollection 2024.
6
Olfactory Neuroblastoma Causing Cushing's Syndrome Due to the Ectopic Adrenocorticotropic Hormone (ACTH) Secretion: A Case Report.因异位促肾上腺皮质激素(ACTH)分泌导致库欣综合征的嗅神经母细胞瘤:一例报告
Cureus. 2024 Mar 19;16(3):e56434. doi: 10.7759/cureus.56434. eCollection 2024 Mar.
7
Olfactory neuroblastoma: diagnosis, management, and current treatment options.嗅神经母细胞瘤:诊断、管理及当前的治疗选择
Front Oncol. 2023 Oct 16;13:1242453. doi: 10.3389/fonc.2023.1242453. eCollection 2023.
8
Treatment outcomes and prognostic factors of esthesioneuroblastoma-a retrospective study from South India.嗅神经母细胞瘤的治疗结果及预后因素——来自印度南部的一项回顾性研究
Ecancermedicalscience. 2023 Jul 27;17:1584. doi: 10.3332/ecancer.2023.1584. eCollection 2023.
9
Olfactory Neuroblastomas: What Actually Happens in the Long-Term?嗅神经母细胞瘤:长期来看实际会发生什么?
J Clin Med. 2022 Apr 20;11(9):2288. doi: 10.3390/jcm11092288.
10
Management of Esthesioneuroblastoma: A Retrospective Study of 6 Cases and Literature Review.嗅神经母细胞瘤的治疗:6例回顾性研究及文献复习
Case Rep Oncol. 2022 Mar 10;15(1):176-186. doi: 10.1159/000521736. eCollection 2022 Jan-Apr.
嗅神经母细胞瘤患者长期预后的优化
Head Neck. 2014 Apr;36(4):524-30. doi: 10.1002/hed.23327. Epub 2013 Jun 18.
4
Esthesioneuroblastoma in pediatric and adolescent age. A report from the TREP project in cooperation with the Italian Neuroblastoma and Soft Tissue Sarcoma Committees.儿童和青少年嗅神经母细胞瘤。与意大利神经母细胞瘤和软组织肉瘤委员会合作的 TREP 项目报告。
BMC Cancer. 2012 Mar 25;12:117. doi: 10.1186/1471-2407-12-117.
5
Improved survival following surgery and radiation therapy for olfactory neuroblastoma: analysis of the SEER database.手术和放疗治疗嗅神经母细胞瘤的生存率提高:SEER 数据库分析。
Radiat Oncol. 2011 Apr 25;6:41. doi: 10.1186/1748-717X-6-41.
6
Posttreatment prognosis of patients with esthesioneuroblastoma.嗅神经母细胞瘤患者的治疗后预后。
J Neurosurg. 2010 Aug;113(2):340-51. doi: 10.3171/2010.2.JNS091897.
7
Treatment of esthesioneuroblastoma: a 16-year meta-analysis of 361 patients.嗅神经母细胞瘤的治疗:对361例患者的16年荟萃分析。
Laryngoscope. 2009 Jul;119(7):1412-6. doi: 10.1002/lary.20280.
8
Esthesioneuroblastoma in childhood and adolescence. Better prognosis with multimodal treatment?儿童和青少年嗅神经母细胞瘤。多模式治疗能否带来更好的预后?
Strahlenther Onkol. 2005 Jun;181(6):378-84. doi: 10.1007/s00066-005-1362-2.
9
Esthesioneuroblastoma in children.儿童嗅神经母细胞瘤
J Pediatr Hematol Oncol. 2002 Aug-Sep;24(6):482-7. doi: 10.1097/00043426-200208000-00015.
10
Esthesioneuroblastoma: a meta-analysis and review.嗅神经母细胞瘤:一项荟萃分析与综述
Lancet Oncol. 2001 Nov;2(11):683-90. doi: 10.1016/S1470-2045(01)00558-7.